Supriya Lifescience Current Share Price | Supriya Lifescience Stock Screener
SUPRIYA
Pharmaceuticals
Supriya Lifescience Current Stock Price Today
Live Share Price NSE
₹906.30
▲
5.65 (0.63%)
Live Share Price BSE
₹905.50
▲
6.75 (0.75%)
As of September 18, 2026, the live Supriya Lifescience share price (NSE: SUPRIYA) is ₹906.30 on NSE and ₹905.50 on BSE, up 0.63% from the previous close, with shares trading between ₹895.75 and ₹920.00 in today's trading session, and a 52-week range of ₹553.35–₹1,052.50.
Browse Supriya Lifescience annual reports to support your investment research.
Use the Supriya Lifescience stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Supriya Lifescience Market Cap
₹7,041.84 Cr.
SUPRIYA P/E Ratio (TTM)
37.27
Supriya Lifescience P/B Ratio
6.17
EPS (TTM)
₹25.98
Dividend Yield
-
Debt to Equity
-
SUPRIYA 52 Week High
₹1052.50
Supriya Lifescience 52 Week Low
₹553.35
Operating Margin
33.00%
Profit Margin
22.40%
SUPRIYA Revenue (TTM)
₹884.00
EBITDA
₹301.00
Net Income
₹198.00
Total Assets
₹1,357.00
Total Equity
₹1,198.00
Supriya Lifescience Current Share Price Chart
Track the current Supriya Lifescience share price and stock price with an interactive chart. Analyse SUPRIYA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Supriya Lifescience stock quote in one place.
Supriya Lifescience Company Profile - Fundamental Screener
Screen Supriya Lifescience company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SUPRIYA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE07RO01027
Supriya Lifescience Balance Sheet Screener
Screen SUPRIYA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,357 | 1,117 | 921 | 820 | 735 | 446 | 336 | 253 | 245 | 241 |
| Current Assets | 532 | 442 | 398 | 465 | 498 | 266 | 196 | 133 | 120 | 115 |
| Fixed Assets | 689 | 453 | 310 | 262 | 190 | 100 | 99 | 85 | 91 | 89 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 38 | 33 | 29 | 25 | 19 | 31 | 32 | 24 | 45 | 51 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,198 | 997 | 815 | 700 | 616 | 269 | 149 | 94 | 55 | 46 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 15 | 15 | 15 | 15 | 15 |
| Reserves & Surplus | 1,182 | 981 | 799 | 683 | 600 | 254 | 134 | 79 | 40 | 31 |
Supriya Lifescience Income Statement Screener - Profit & Revenue Analysis
Screen Supriya Lifescience income statement and profit fundamentals.
Analyze SUPRIYA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Supriya Lifescience share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 884 | 839 | 706 | 581 | 470 | 538 | 396 | 323 | 286 | 222 | 191 | 172 | 140 |
| Expenses | 583 | 534 | 436 | 397 | 332 | 316 | 218 | 213 | 213 | 191 | 166 | 150 | 121 |
| EBITDA | 301 | 306 | 271 | 184 | 138 | 222 | 178 | 110 | 73 | 31 | 25 | 22 | 20 |
| Operating Profit % | 33.00% | 36.00% | 37.00% | 30.00% | 28.00% | 40.00% | 44.00% | 32.00% | 23.00% | 10.00% | 9.00% | 12.00% | 12.00% |
| Depreciation | 31 | 28 | 20 | 16 | 12 | 10 | 7 | 6 | 5 | 5 | 5 | 4 | 3 |
| Interest | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 7 | 10 | 11 | 12 | 10 | 7 |
| Profit Before Tax | 268 | 275 | 249 | 166 | 124 | 207 | 167 | 96 | 57 | 15 | 8 | 8 | 10 |
| Tax | 59 | 66 | 61 | 47 | 34 | 55 | 44 | 23 | 18 | 6 | 2 | 2 | 2 |
| Net Profit | 198 | 209 | 188 | 119 | 90 | 152 | 124 | 73 | 39 | 9 | 6 | 6 | 8 |
| EPS | 24.70 | 25.98 | 23.35 | 14.80 | 11.16 | 18.86 | 16.89 | 10.02 | 5.39 | 1.19 | 3.87 | 3.89 | 16.82 |
Supriya Lifescience Cash Flow Screener - Liquidity Fundamentals
Screen SUPRIYA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 186 | 165 | 113 | 64 | 49 | 76 | 117 | 49 | 28 | 27 |
| Investing Activities | -176 | -152 | -174 | -124 | -60 | -47 | -25 | 5 | -5 | -27 |
| Financing Activities | -10 | -8 | -22 | -10 | 150 | -15 | -29 | -50 | -20 | -2 |
| Net Cash Flow | 0 | 4 | -83 | -70 | 139 | 15 | 62 | 4 | 3 | -2 |
Supriya Lifescience Shareholding Pattern Screener
See Supriya Lifescience shareholding pattern with promoter, FII, and DII holdings.
Check Supriya Lifescience promoter holding and ownership changes for SUPRIYA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% |
| FII Holding | 5.16% | 6.19% | 7.19% | 6.78% | 5.46% | 5.20% | 5.36% | 4.95% |
| DII Holding | 5.70% | 5.30% | 4.26% | 4.86% | 5.22% | 5.01% | 5.30% | 5.48% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.22% | 15.98% | 16.40% | 16.39% | 16.77% | 16.66% | 17.06% | 17.19% |
| Other Holding | 4.63% | 4.23% | 3.85% | 3.67% | 4.25% | 4.83% | 3.98% | 4.08% |
| Shareholder Count | 81,161 | 82,082 | 91,051 | 91,928 | 87,912 | 85,099 | 87,980 | 89,621 |
Supriya Lifescience Share Dividend Screener - Share Yield Analysis
Check Supriya Lifescience dividend history with payout and yield data.
View Supriya Lifescience dividend details including ex-dates and amounts for SUPRIYA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.00 | 0.11% |
| 2025-March | ₹1.00 | 0.18% |
| 2024-March | ₹0.80 | 0.11% |
| 2023-March | ₹0.60 | 0.18% |
| 2022-March | ₹0.60 | 0.32% |
| 2021-March | ₹0.54 | 0.11% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Supriya Lifescience Stock Index Membership
See which indices include Supriya Lifescience stock.
Check SUPRIYA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Supriya Lifescience Market Events Screener - Corporate Actions
Get Supriya Lifescience corporate actions including splits, bonuses, and buybacks.
Check Supriya Lifescience stock events that may affect SUPRIYA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 14.17% |
| 2026-09-04 | 2026-09-04 | Dividend | ₹ 1.00 /share | 8.03% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -9.00% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 8.24% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 0.36% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -6.66% |
| 2025-09-24 | 2025-09-24 | Annual General Meeting | NA | 11.37% |
| 2025-09-04 | 2025-09-05 | Dividend | ₹ 1.00 /share | -11.70% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -0.96% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 5.82% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 9.11% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -1.41% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -6.20% |
| 2024-09-20 | 2024-09-21 | Dividend | ₹ 0.80 /share | 74.84% |
| 2023-09-15 | 2023-09-15 | Dividend | ₹ 0.60 /share | 13.53% |
Supriya Lifescience Competitors Screener - Peer Comparison
Screen SUPRIYA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Supriya Lifescience Company Announcements - News Screener
Screen SUPRIYA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-02 | Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company | - |
| 2026-09-02 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015. | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-01 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-01 | Notice Of 18Th Annual General Meeting Of The Company. | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-26 | Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26. | - |
| 2026-08-22 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-22 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Unaudited Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On August 13 2026 | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-06 | Board Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026 | - |